Despite difficult conditions, Novartis is increasing sales through the launch of innovative therapies, a clear focus on growth markets, and productivity-oriented cost control.
The leaders of Merck have picked their priorities – immuno-oncology, Alzheimer’s, HCV, and externally sourced R&D – and are reshaping their company accordingly.
With more than a third of its 2011 revenue now off-patent, Eli Lilly is looking to its late-stage pipeline to restore the company’s fortunes.
Johnson & Johnson is the global healthcare sales leader, successfully delivering strong results via all four of the company’s long-term growth platforms.
575 Lexington AvenueNew York, NY 10022Telephone: 212-971-1345 602 Walnut Street, Suite 250-SPhiladelphia, PA 19105Telephone: 215-238-8500 E-mail: [email protected]: calciumnyc.com Quick Facts Accounts Account wins 10 Accounts resigned 2 Active business […]
225 North Michigan AvenueChicago, IL 60601Telephone: 312-297-6700Facsimile: 312-297-6701E-mail: [email protected]: cahg.com Winner BRAND TEAM OF THE YEAR Quick Facts Accounts Account wins 3 Active business clients 18 Brands by 2013 […]